Finance

Lists
Why is TLPPF down 9,11%?
Dive Deeper
TLPPF:OTCMKTS
Telix Pharmaceuticals Ltd
11,27 US$
-9,11%
(-1,13) 1D
30 სექ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TLPPF...
Open
11,26 US$
High
11,27 US$
Low
11,26 US$
Mkt. cap
5,31 მლრდ.
Avg. vol.
3,00 ათ.
Volume
1,74 ათ.
52-wk high
13,00 US$
52-wk low
5,91 US$
Beta
1,66
Shares outstanding
339,89 მლნ.
No. of employees
1 ათ.
Open
11,26 US$
High
11,27 US$
Low
11,26 US$
Mkt. cap
5,31 მლრდ.
Avg. vol.
3,00 ათ.
Volume
1,74 ათ.
52-wk high
13,00 US$
52-wk low
5,91 US$
Beta
1,66
Shares outstanding
339,89 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
About Telix Pharmaceuticals Ltd
CEOქრისტიან ბერენბრუჩ
Employees1,15 ათ.
Founded2015
Headquarters-
Sector-
Websitetelixpharma.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
206,72 მლნ.
206,72 მლნ.
238,68 მლნ.
238,68 მლნ.
Cost of goods sold
110,68 მლნ.
110,68 მლნ.
122,86 მლნ.
122,86 მლნ.
Cost of revenue
110,68 მლნ.
110,68 მლნ.
122,86 მლნ.
122,86 მლნ.
Research and development expenses
44,83 მლნ.
44,83 მლნ.
61,91 მლნ.
61,91 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
47,93 მლნ.
47,93 მლნ.
53,51 მლნ.
53,51 მლნ.
Operating expense
92,02 მლნ.
92,02 მლნ.
92,64 მლნ.
92,64 მლნ.
Total operating expenses
202,70 მლნ.
202,70 მლნ.
215,49 მლნ.
215,49 მლნ.
Operating income
4,02 მლნ.
4,02 მლნ.
23,18 მლნ.
23,18 მლნ.
Other non operating income
-7,23 მლნ.
-7,23 მლნ.
-7,45 მლნ.
-7,45 მლნ.
EBT including unusual items
-215,00 ათ.
-215,00 ათ.
14,62 მლნ.
14,62 მლნ.
EBT excluding unusual items
-6,75 მლნ.
-6,75 მლნ.
13,16 მლნ.
13,16 მლნ.
Income tax expense
2,20 მლნ.
2,20 მლნ.
-4,54 მლნ.
-4,54 მლნ.
Effective tax rate
-1 023,95%
-1 023,95%
-31,05%
-31,05%
Other operating expenses
-745,50 ათ.
-745,50 ათ.
-22,79 მლნ.
-22,79 მლნ.
Net income
-2,42 მლნ.
-2,42 მლნ.
19,16 მლნ.
19,16 მლნ.
Net profit margin
-1,17%
-1,17%
8,03%
8,03%
Earnings per share
-
-
-
-
Interest and investment income
1,10 მლნ.
1,10 მლნ.
1,14 მლნ.
1,14 მლნ.
Interest expense
-3,78 მლნ.
-3,78 მლნ.
-3,71 მლნ.
-3,71 მლნ.
Net interest expenses
-2,68 მლნ.
-2,68 მლნ.
-2,57 მლნ.
-2,57 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
7,09 მლნ.
7,09 მლნ.
28,66 მლნ.
28,66 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები